Appeal No. 95-4700 Application 07/837,668 encodes “at least one epitope of a heterologous organism.” As set forth in claim 1 on appeal, the second nucleotide sequence is “inserted within the flagellin sequence.” The fusion protein expressed by the recombinant gene must be “capable of binding to an antiflagellin antibody.” Asaka describes a nucleotide sequence denominated as the hag gene which codes for flagellin of E. coli. See Figure 1 of Asaka. As set forth in the paragraph bridging columns 2-3 of Asaka: The present inventors remarked [sic] an excretion system of flagellin in investigating a system in which a target peptide is produced outside of a cell. Therefore, the whole base sequence of hag gene encoding flagellin was determined and the gene was inserted into a vector and then the hag gene on the vector was cut or a part of the gag gene on the vector was removed and into the resulting space is inserted linker DNA. Into the linker DNA in the vector is inserted DNA coding for a foreign peptide and the resulting vector in introduced into bacteria. As a result, the foreign peptide is excreted from the bacteria as a fused peptide with flagellin. Under certain condition the excreted peptide forms flagella, which facilitates the recovery of the peptide. Moreover, it may be possible that some foreign peptides which could not be secreted from bacteria by conventional secretion systems are excreted by this excretion system. 5Page: Previous 1 2 3 4 5 6 7 8 9 NextLast modified: November 3, 2007